Fig. 8From: Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry – a prospectively controlled randomized double-blind clinical trialMaximum clot firmness measured by INTEM, EXTEM and FIBTEM over time. In all panels data are depicted as boxes showing median and interquartile range, whiskers indicate 1.5 times interquartile range. Outliers are depicted as circles and stars. There were no statistically significant differences within the argatroban or lepirudin group as compared to baseline or between the argatroban and lepirudin group: a) INTEM MCF, b) EXTEM MCF, c) FIBTEM MCFBack to article page